OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Minas P. Economides, David A. Rizzieri, Naveen Pemmaraju
Current Hematologic Malignancy Reports (2019) Vol. 14, Iss. 6, pp. 515-522
Closed Access | Times Cited: 13
Minas P. Economides, David A. Rizzieri, Naveen Pemmaraju
Current Hematologic Malignancy Reports (2019) Vol. 14, Iss. 6, pp. 515-522
Closed Access | Times Cited: 13
Showing 13 citing articles:
Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia
Mayumi Sugita, Román Galetto, Hongliang Zong, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Mayumi Sugita, Román Galetto, Hongliang Zong, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Blood cancer: Current and new drug delivery systems
Mahendra Saini, Afrasim Moin, Vikash Kumar Yadav, et al.
Elsevier eBooks (2025), pp. 321-349
Closed Access
Mahendra Saini, Afrasim Moin, Vikash Kumar Yadav, et al.
Elsevier eBooks (2025), pp. 321-349
Closed Access
More on Blastic Plasmacytoid Dendritic-Cell Neoplasms
Naveen Pemmaraju, Marina Konopleva, Andrew A. Lane
New England Journal of Medicine (2019) Vol. 380, Iss. 7, pp. 695-697
Closed Access | Times Cited: 32
Naveen Pemmaraju, Marina Konopleva, Andrew A. Lane
New England Journal of Medicine (2019) Vol. 380, Iss. 7, pp. 695-697
Closed Access | Times Cited: 32
Blastic plasmacytoid dendritic cell neoplasm (BPDCN ): A promising future in the era of targeted therapeutics
Ijele Adimora, Nathaniel R. Wilson, Naveen Pemmaraju
Cancer (2022) Vol. 128, Iss. 16, pp. 3019-3026
Closed Access | Times Cited: 17
Ijele Adimora, Nathaniel R. Wilson, Naveen Pemmaraju
Cancer (2022) Vol. 128, Iss. 16, pp. 3019-3026
Closed Access | Times Cited: 17
CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123
Xiaoyi Hu, Asiri Ediriwickrema, Atif Saleem, et al.
Leukemia Research (2024) Vol. 139, pp. 107479-107479
Closed Access | Times Cited: 2
Xiaoyi Hu, Asiri Ediriwickrema, Atif Saleem, et al.
Leukemia Research (2024) Vol. 139, pp. 107479-107479
Closed Access | Times Cited: 2
Bromodomain and extra-terminal (BET) inhibitors in treating myeloid neoplasms
Natalie Cheng Chen, Gautam Borthakur, Naveen Pemmaraju
Leukemia & lymphoma/Leukemia and lymphoma (2020) Vol. 62, Iss. 3, pp. 528-537
Closed Access | Times Cited: 15
Natalie Cheng Chen, Gautam Borthakur, Naveen Pemmaraju
Leukemia & lymphoma/Leukemia and lymphoma (2020) Vol. 62, Iss. 3, pp. 528-537
Closed Access | Times Cited: 15
Blastic plasmocitoid dendritic cell neoplasm with leukemic spread: a GIMEMA survey
Caterina Giovanna Valentini, Alfonso Piciocchi, Fabio Facchetti, et al.
Blood Advances (2021) Vol. 5, Iss. 24, pp. 5608-5611
Open Access | Times Cited: 13
Caterina Giovanna Valentini, Alfonso Piciocchi, Fabio Facchetti, et al.
Blood Advances (2021) Vol. 5, Iss. 24, pp. 5608-5611
Open Access | Times Cited: 13
Targeting CD123 in BPDCN: an emerging field
Adam J. DiPippo, Nathaniel R. Wilson, Naveen Pemmaraju
Expert Review of Hematology (2021) Vol. 14, Iss. 11, pp. 993-1004
Closed Access | Times Cited: 10
Adam J. DiPippo, Nathaniel R. Wilson, Naveen Pemmaraju
Expert Review of Hematology (2021) Vol. 14, Iss. 11, pp. 993-1004
Closed Access | Times Cited: 10
Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning regimen for blastic plasmacytoid dendritic cell neoplasm patients in complete remission: a single center study
Yue Lü, Ruijuan Sun, Jianping Zhang, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 13, pp. 3092-3099
Closed Access | Times Cited: 4
Yue Lü, Ruijuan Sun, Jianping Zhang, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 13, pp. 3092-3099
Closed Access | Times Cited: 4
Blastic plasmacytoid dendritic cell neoplasm with cutaneous presentation: A case series in children
Grace Chan, Similolu Akintorin, Minnelly Luu, et al.
Pediatric Dermatology (2021) Vol. 38, Iss. 4, pp. 883-886
Closed Access | Times Cited: 3
Grace Chan, Similolu Akintorin, Minnelly Luu, et al.
Pediatric Dermatology (2021) Vol. 38, Iss. 4, pp. 883-886
Closed Access | Times Cited: 3
Rapidly progressing blastic plasmacytoid dendritic cell neoplasm causing diffuse skin thickening: A case report with sequential computed tomography examinations
Kyohei Yoshioka, Ryo Kurokawa, Shiori Amemiya, et al.
Radiology Case Reports (2021) Vol. 16, Iss. 10, pp. 2929-2933
Open Access | Times Cited: 2
Kyohei Yoshioka, Ryo Kurokawa, Shiori Amemiya, et al.
Radiology Case Reports (2021) Vol. 16, Iss. 10, pp. 2929-2933
Open Access | Times Cited: 2
Blastic Plasmacytoid Dendritic Cell Neoplasm: A 10-year Bibliometric Study
Carlos Quispe‐Vicuña, Miguel Cabanillas‐Lazo, John Barja–Ore, et al.
Journal of Applied Hematology (2023) Vol. 14, Iss. 1, pp. 12-16
Open Access
Carlos Quispe‐Vicuña, Miguel Cabanillas‐Lazo, John Barja–Ore, et al.
Journal of Applied Hematology (2023) Vol. 14, Iss. 1, pp. 12-16
Open Access
A case of blastic plasmacytoid dendritic cell neoplasm limited to skin
Xinlyu Huang, Liwei Ran
Dermatologic Therapy (2022) Vol. 35, Iss. 7
Open Access
Xinlyu Huang, Liwei Ran
Dermatologic Therapy (2022) Vol. 35, Iss. 7
Open Access
